Advanced Oncotherapy PLC’s (AIM:AVO) chief executive Nicolas Serandour tells Proactive’s Thomas Warner that it was a huge milestone for the business to get its proton beam therapy system running at full capacity.
AVO’s LIGHT system, which is significantly smaller than the existing standard-of-care technology, recently produced a proton beam at 230 megaelectron volts (MeV) at its assembly site in Daresbury, Cheshire, something he says was a key step in its development.
The company now has all the ammunition it needs to meet its objective to “democratise proton therapy” for the treatment of cancer tumours, he adds, with the next stage being first patients at Daresbury ‘in the second half of next year’.
#ProactiveInvestors #AdvancedOncotherapy #LIGHT #AIM
